查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2081905

小鼠模型市場：2026-2032年全球市場預測（按模型類型、年齡層、採購方式、疾病誘導方法、應用和最終用戶分類）

Mice Model Market by Model Type, Age Cohort, Procurement Format, Disease Induction Method, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，小鼠模型市場規模將成長至 31.1 億美元，複合年成長率為 8.66%。

主要市場統計數據
基準年 2025 17.4億美元
預計年份：2026年 18.8億美元
預測年份：2032年 31.1億美元
複合年成長率 (%) 8.66%

小鼠模型市場作為臨床前研究的基礎，仍然至關重要。這是因為實驗小鼠模型提供了可進行基因操作、高度可重複且具有生物學相關性的系統，可用於研究人類疾病。小鼠和人類生物學之間存在著許多遺傳和生理上的相似性，支撐了它們在腫瘤學、免疫學、代謝性疾病、神經科學、感染疾病、毒理學和疫苗研究等領域的持續應用。

對於臨床前模型供應商和受託研究機構(CRO) 而言，需求日益集中於人源化小鼠、基因轉殖小鼠、基因敲除小鼠、患者來源的異種移植模型、無菌模型、免疫力缺乏品係以及疾病特異性體內平台。隨著製藥公司在進行臨床投資前尋求可靠的轉化證據，買家優先考慮的是檢驗的表現型、可重複的背景品系、嚴格遵守動物福利標準、明確的微生物狀態以及更短的研究週期。

小鼠模型環境的變革性變化

小鼠模型的格局正從標準化的種群供應轉向專業化的、數據豐富的臨床前解決方案。 CRISPR-Cas9基因編輯技術正在加速建構標靶敲除、敲入、條件性及報告基因小鼠模型，而人源化免疫系統模型和患者來源的異種移植模型正在腫瘤學、免疫腫瘤學、自體免疫疾病和感染疾病檢測領域拓展其應用。

人工智慧的累積影響

人工智慧（AI）正成為小鼠模型整個價值鏈中一股切實的驅動力。 AI驅動的影像分析、自動行為追蹤、數位病理學、高內涵表現型分析和時間序列監測有助於減少觀察者偏差，並從每項研究中提取更多終點指標，從而支持3R框架中的「簡化原則」。

關於小鼠模型供應商的關鍵區域見解

北美憑藉其生物製藥研發中心、美國國立衛生研究院（NIH）資助的學術研究、先進的動物飼養基礎設施以及成熟的合約研究能力，仍然是小鼠模型服務的主要中心。在歐洲，儘管歐盟指令2010/63/EU、嚴格的倫理審查以及3R原則的廣泛應用持續推動著以動物福利為中心的創新，但對基因修飾小鼠模型、腫瘤模型、免疫學平台和藥理學研究的強勁需求依然存在。

按調查區域進行的主要群體分析

隨著新加坡、泰國、馬來西亞、越南、印尼和菲律賓不斷加強其生物醫學研究生態系統、實驗室能力和跨國學術合作，東協市場在臨床前外包領域的重要性日益凸顯。海灣合作理事會（GCC）正加大對精準醫療、大學附屬醫療中心、基因組學計畫和醫療創新策略的投資，從而對高品質的動物研究夥伴關係、進口特種品係以及符合監管要求的臨床前測試支持產生了特定的需求。

主要國家滑鼠模型市場趨勢

美國憑藉美國國立衛生研究院 (NIH) 的資助、生物製藥研發管線、專業的動物繁殖設施基礎設施以及成熟的合約研究組織 (CRO) 的能力，是先進小鼠模型服務的最大戰略市場。加拿大在強大的學術研究、轉化醫學網路和倫理監管方面發揮著重要作用，而墨西哥則支持區域研究、與生產相關的生命科學活動以及不斷發展的臨床和生物醫學領域的合作。巴西憑藉其一流的大學、生物醫學實驗室、感染疾病知識和完善的公共研究體系，在拉丁美洲處於領先地位。

為行業領導者提供的實用建議

產業供應商應將模型檢驗、基因真實性驗證、微生物及微生物組管理、環境標準化以及透明的研究文件作為核心差異化優勢。能夠證明其研究結果在不同研究中心間具有可重複性、符合倫理規範、擁有完善的品質保證體係以及能夠達到臨床相關終點的供應商，將更有利於與製藥、生物技術、學術和政府研究機構的客戶建立高價值的夥伴關係。

調查方法

本執行摘要基於檢驗的行業知識，涵蓋臨床前研究、實驗動物科學、基因組學、監管指南、生物醫學研發趨勢以及轉化醫學實踐。分析內容參考了既定框架，包括3R原則、ARRIVE報告指南、歐盟動物實驗法規、機構特定的動物照護和使用要求，以及在基因修飾小鼠、免疫力缺乏小鼠、無菌小鼠和人源化小鼠模型開發方面的既定實踐。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：小鼠模型市場：依模型類型分類

  • 基因改造小鼠模型
    • 條件性敲除模型
    • 人源化小鼠模型
    • 淘汰賽模特兒
    • 基因改造模型
  • 近交系小鼠模型
  • 非近交系小鼠模型

第8章：小鼠模型市場：依年齡層別分類

  • 胚胎期
  • 新生
  • 童年
  • 成人
  • 老年

第9章：小鼠模型市場：依採購方式分類

  • 活體動物
    • 實驗組
    • 繁殖個體
    • 已確定妊娠期的雌性小鼠
  • 冷凍保存材料
    • 胚胎
    • 精子

第10章：小鼠模型市場：依疾病誘導法分類

  • 自發性模型
  • 化學誘導模型
  • 餵食誘導模型
  • 手術誘導模型
  • 感染誘導模型

第11章：小鼠模型市場：依應用分類

  • 行為研究
  • 心血管疾病
  • 藥物發現與毒理學
  • 遺傳疾病研究
  • 免疫學
  • 感染疾病
  • 代謝性疾病
  • 神經病學和神經退化性疾病
  • 癌症研究

第12章 滑鼠模型市場：依最終使用者分類

  • 學術和研究機構
  • 受託研究機構（CRO）
  • 醫院和診斷中心
  • 製藥和生物技術公司

第13章 小鼠模型市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 小鼠模型市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 小鼠模型市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Applied StemCell, Inc.
  • Aragen Life Sciences Ltd.
  • Biocytogen Boston Corporation
  • Charles River Laboratories International, Inc.
  • Creative Biolabs
  • Crown Bioscience by JSR Life Sciences, LLC
  • Cyagen Biosciences Suzhou Inc.
  • Cyagen US Inc. by PolyGene AG
  • Envigo by Inotiv, Inc.
  • GemPharmatech Co., Ltd.
  • GenOway
  • Harbour BioMed
  • Hera BioLabs, Inc.
  • inGenious Targeting Laboratory, Inc.
  • Janvier Labs
  • Marshall BioResources
  • MD Biosciences
  • Mirimus, Inc.
  • Ozgene Pty Ltd.
  • PhoenixBio Co., Ltd.
  • Shanghai Model Organisms Center, Inc.
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • TransCure bioServices
  • Translational Drug Development, LLC
  • Urosphere SAS
  • Vitalstar BIoTechnology Co., Ltd.
  • XenOPAT SL by Bellvitge Biomedical Research Institute
Product Code: MRR-4316E4E89369

The Mice Model Market is projected to grow by USD 3.11 billion at a CAGR of 8.66% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.74 billion
Estimated Year [2026] USD 1.88 billion
Forecast Year [2032] USD 3.11 billion
CAGR (%) 8.66%

The mice model market remains a foundational pillar of preclinical research because laboratory mouse models provide genetically tractable, reproducible, and biologically relevant systems for studying human disease. Mouse and human biology share extensive genetic and physiological similarities, supporting continued use in oncology, immunology, metabolic disease, neuroscience, infectious disease, toxicology, and vaccine research.

For preclinical model providers and contract research organizations, demand is increasingly concentrated around humanized mice, transgenic mice, knockout mice, patient-derived xenograft models, germ-free models, immunodeficient strains, and disease-specific in vivo platforms. Buyers are prioritizing validated phenotypes, reproducible background strains, strong animal welfare compliance, defined microbial status, and faster study turnaround as drug developers seek higher-confidence translational evidence before clinical investment.

Transformative Shifts in the Mice Model Landscape

The mice model landscape is shifting from standardized colony supply toward specialized, data-rich preclinical solutions. CRISPR-Cas9 genome editing has accelerated the creation of targeted knockout, knock-in, conditional, and reporter mouse models, while humanized immune system models and patient-derived xenograft platforms are expanding their role in oncology, immuno-oncology, autoimmune disease, and infectious disease testing.

Regulatory and ethical expectations are also reshaping purchasing behavior. The 3Rs principles of replacement, reduction, and refinement, ARRIVE reporting guidelines, and institutional animal care standards are pushing providers to document welfare practices, genetic integrity, microbial status, study reproducibility, and endpoint justification. This transformation favors partners that combine scientific customization with transparent quality systems and robust in vivo research governance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical enabler across the mice model value chain. AI-supported image analysis, automated behavioral tracking, digital pathology, high-content phenotyping, and longitudinal monitoring help reduce observer bias and extract more endpoints from each study, supporting the reduction principle within the 3Rs framework.

For model providers, AI also improves colony management, breeding forecasts, genotype-phenotype interpretation, and study design optimization. Predictive analytics can help identify appropriate cohort structures, reduce failed breeding cycles, flag welfare anomalies, and detect outliers earlier. The strongest commercial advantage will come from integrating AI with validated wet-lab workflows, controlled experimental design, and expert biological interpretation rather than positioning algorithms as substitutes for translational evidence.

Key Regional Insights for Mice Model Providers

North America remains a leading hub for mice model services due to its dense concentration of biopharmaceutical R&D, NIH-funded academic research, advanced vivarium infrastructure, and established contract research capabilities. Europe continues to emphasize welfare-driven innovation through EU Directive 2010/63/EU, rigorous ethical review, and broad adoption of the 3Rs, while maintaining strong demand for genetically engineered mouse models, oncology models, immunology platforms, and pharmacology studies.

Asia-Pacific is expanding as China, Japan, South Korea, India, Australia, and Singapore invest in translational medicine, genome editing, oncology research infrastructure, and regulated preclinical capabilities. Latin America is led by Brazil and Mexico in biomedical research capacity, infectious disease studies, and academic animal research programs, while the Middle East is building biomedical clusters, precision medicine initiatives, and hospital-linked research programs across the GCC. Africa remains earlier stage but is gaining relevance through infectious disease research, public health collaborations, vaccine-related studies, and university-led laboratory animal programs that support region-specific biomedical priorities.

Key Group Insights Across Research Blocs

ASEAN markets are increasingly important for preclinical outsourcing as Singapore, Thailand, Malaysia, Vietnam, Indonesia, and the Philippines strengthen biomedical research ecosystems, laboratory capacity, and multinational academic collaborations. GCC countries are investing in precision medicine, academic medical centers, genomics programs, and healthcare innovation strategies, creating selective demand for high-quality animal research partnerships, imported specialized strains, and compliant preclinical testing support.

The European Union sets a global benchmark for animal welfare governance, data transparency, harmonized compliance, and structured ethical assessment under Directive 2010/63/EU. BRICS countries, especially China, India, and Brazil, are expanding domestic capabilities in genetic engineering, disease modeling, biomanufacturing-linked research, and translational medicine. G7 markets remain premium buyers of validated mice models due to mature biopharmaceutical pipelines, strong academic funding, and advanced regulatory expectations, while NATO-aligned countries benefit from biomedical security, infectious disease preparedness, trauma research, and defense-related medical research priorities that sustain demand for reliable in vivo models.

Key Country Insights in the Mice Model Market

The United States is the largest strategic market for advanced mice model services, supported by NIH funding, biopharma pipelines, specialized vivarium infrastructure, and mature CRO capacity. Canada contributes strong academic research, translational medicine networks, and ethical oversight, while Mexico supports regional research, manufacturing-linked life sciences activity, and growing clinical and biomedical collaboration. Brazil leads Latin America through major universities, biomedical institutes, infectious disease expertise, and established public research systems.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong demand for transgenic mice, knockout models, oncology models, and disease-specific platforms under strict animal welfare systems, while Russia retains scientific capacity in biomedical research despite geopolitical and collaboration constraints. China is scaling domestic model production, CRISPR capabilities, humanized mouse platforms, and oncology research capacity; India is expanding translational research, vaccine development, and pharmacology capabilities; Japan and South Korea remain advanced innovation hubs for regenerative medicine, immunology, oncology, and precision research; and Australia supports immunology, oncology, neuroscience, and infectious disease research through well-regulated institutions and strong university-led biomedical programs.

Actionable Recommendations for Industry Leaders

Industry vendors should prioritize model validation, genetic authentication, microbial and microbiome control, environmental standardization, and transparent study documentation as core differentiators. Providers that can demonstrate reproducibility across sites, ethical compliance, robust quality assurance, and clinically relevant endpoints will be better positioned for high-value partnerships with pharmaceutical, biotechnology, academic, and government research clients.

Commercial teams should invest in humanized models, patient-derived xenograft libraries, CRISPR-enabled custom model generation, germ-free and gnotobiotic capabilities, and AI-enhanced phenotyping. Partnerships with academic disease centers, biobanks, and translational research networks can strengthen scientific credibility. Vendors should also communicate 3Rs-aligned study design, because buyers increasingly view welfare, data integrity, operational efficiency, and regulatory readiness as linked performance indicators in preclinical research outsourcing.

Research Methodology

This executive summary is built from verified industry knowledge across preclinical research, laboratory animal science, genome engineering, regulatory guidance, biomedical R&D trends, and translational medicine practices. The analysis reflects established frameworks including the 3Rs principles, ARRIVE reporting guidance, EU animal research rules, institutional animal care and use requirements, and recognized practices in genetically engineered, immunodeficient, germ-free, and humanized mouse model development.

Market interpretation focuses on evidence-backed demand drivers rather than speculative claims. Regional, group, and country insights are assessed through observable research capacity, biopharmaceutical activity, regulatory maturity, academic infrastructure, public health priorities, and translational medicine investment. Conclusion

The mice model market is evolving from a commodity animal supply segment into a precision preclinical research ecosystem. Industry direction is being shaped by humanized models, CRISPR-edited strains, patient-derived xenograft platforms, oncology and immunology applications, infectious disease research, AI-enabled phenotyping, and rising expectations for reproducible, welfare-conscious science.

For providers and CROs, competitive advantage will depend on scientific depth, operational quality, data transparency, animal welfare alignment, and the ability to comply with global research standards. Organizations that integrate ethical animal research with advanced disease modeling, controlled study design, and digital analytics will be best positioned to serve the next generation of translational medicine.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Mice Model Market, by Model Type

  • 7.1. Genetically Engineered Mice Models
    • 7.1.1. Conditional Knockout Models
    • 7.1.2. Humanized Mice Models
    • 7.1.3. Knockout Models
    • 7.1.4. Transgenic Models
  • 7.2. Inbred Mice Models
  • 7.3. Outbred Mice Models

8. Mice Model Market, by Age Cohort

  • 8.1. Embryonic
  • 8.2. Neonatal
  • 8.3. Juvenile
  • 8.4. Adult
  • 8.5. Aged

9. Mice Model Market, by Procurement Format

  • 9.1. Live Animals
    • 9.1.1. Experimental Cohorts
    • 9.1.2. Breeding Stock
    • 9.1.3. Timed-Pregnant Females
  • 9.2. Cryopreserved Materials
    • 9.2.1. Embryos
    • 9.2.2. Sperm

10. Mice Model Market, by Disease Induction Method

  • 10.1. Spontaneous Models
  • 10.2. Chemically Induced Models
  • 10.3. Diet-Induced Models
  • 10.4. Surgically Induced Models
  • 10.5. Infection-Induced Models

11. Mice Model Market, by Application

  • 11.1. Behavioral Studies
  • 11.2. Cardiovascular Diseases
  • 11.3. Drug Discovery & Toxicology
  • 11.4. Genetic Disease Research
  • 11.5. Immunology
  • 11.6. Infectious Diseases
  • 11.7. Metabolic Disorders
  • 11.8. Neurology & Neurodegenerative Diseases
  • 11.9. Oncology Research

12. Mice Model Market, by End User

  • 12.1. Academic & Research Institutions
  • 12.2. Contract Research Organizations (CROs)
  • 12.3. Hospitals & Diagnostic Centers
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Mice Model Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Mice Model Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Mice Model Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Applied StemCell, Inc.
  • 17.2. Aragen Life Sciences Ltd.
  • 17.3. Biocytogen Boston Corporation
  • 17.4. Charles River Laboratories International, Inc.
  • 17.5. Creative Biolabs
  • 17.6. Crown Bioscience by JSR Life Sciences, LLC
  • 17.7. Cyagen Biosciences Suzhou Inc.
  • 17.8. Cyagen US Inc. by PolyGene AG
  • 17.9. Envigo by Inotiv, Inc.
  • 17.10. GemPharmatech Co., Ltd.
  • 17.11. GenOway
  • 17.12. Harbour BioMed
  • 17.13. Hera BioLabs, Inc.
  • 17.14. inGenious Targeting Laboratory, Inc.
  • 17.15. Janvier Labs
  • 17.16. Marshall BioResources
  • 17.17. MD Biosciences
  • 17.18. Mirimus, Inc.
  • 17.19. Ozgene Pty Ltd.
  • 17.20. PhoenixBio Co., Ltd.
  • 17.21. Shanghai Model Organisms Center, Inc.
  • 17.22. Taconic Biosciences, Inc.
  • 17.23. The Jackson Laboratory
  • 17.24. TransCure bioServices
  • 17.25. Translational Drug Development, LLC
  • 17.26. Urosphere SAS
  • 17.27. Vitalstar Biotechnology Co., Ltd.
  • 17.28. XenOPAT SL by Bellvitge Biomedical Research Institute

LIST OF FIGURES

  • FIGURE 1. GLOBAL MICE MODEL MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL MICE MODEL MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL MICE MODEL MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL MICE MODEL MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL MICE MODEL MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL MICE MODEL MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MICE MODEL MARKET SIZE, BY AGE COHORT, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL MICE MODEL MARKET SIZE, BY AGE COHORT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL MICE MODEL MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL MICE MODEL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL MICE MODEL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL MICE MODEL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GENETICALLY ENGINEERED MICE MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GENETICALLY ENGINEERED MICE MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GENETICALLY ENGINEERED MICE MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONDITIONAL KNOCKOUT MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONDITIONAL KNOCKOUT MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONDITIONAL KNOCKOUT MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HUMANIZED MICE MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HUMANIZED MICE MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HUMANIZED MICE MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL KNOCKOUT MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL KNOCKOUT MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL KNOCKOUT MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TRANSGENIC MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TRANSGENIC MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TRANSGENIC MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INBRED MICE MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INBRED MICE MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INBRED MICE MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OUTBRED MICE MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OUTBRED MICE MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OUTBRED MICE MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EMBRYONIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EMBRYONIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EMBRYONIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEONATAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEONATAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEONATAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL JUVENILE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL JUVENILE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL JUVENILE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AGED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AGED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AGED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LIVE ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LIVE ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LIVE ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL EXPERIMENTAL COHORTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXPERIMENTAL COHORTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL EXPERIMENTAL COHORTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREEDING STOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BREEDING STOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREEDING STOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TIMED-PREGNANT FEMALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TIMED-PREGNANT FEMALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TIMED-PREGNANT FEMALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CRYOPRESERVED MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CRYOPRESERVED MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CRYOPRESERVED MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EMBRYOS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EMBRYOS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EMBRYOS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SPERM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SPERM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SPERM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SPONTANEOUS MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SPONTANEOUS MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SPONTANEOUS MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CHEMICALLY INDUCED MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CHEMICALLY INDUCED MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CHEMICALLY INDUCED MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIET-INDUCED MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIET-INDUCED MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIET-INDUCED MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICALLY INDUCED MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICALLY INDUCED MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICALLY INDUCED MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INFECTION-INDUCED MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INFECTION-INDUCED MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INFECTION-INDUCED MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BEHAVIORAL STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BEHAVIORAL STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BEHAVIORAL STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DRUG DISCOVERY & TOXICOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DRUG DISCOVERY & TOXICOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DRUG DISCOVERY & TOXICOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GENETIC DISEASE RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GENETIC DISEASE RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GENETIC DISEASE RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL IMMUNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL IMMUNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NEUROLOGY & NEURODEGENERATIVE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROLOGY & NEURODEGENERATIVE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NEUROLOGY & NEURODEGENERATIVE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ONCOLOGY RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ONCOLOGY RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ONCOLOGY RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL MICE MODEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 196. GCC MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 197. GCC MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 199. GCC MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. GCC MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. G7 MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. G7 MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 229. G7 MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. G7 MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. NATO MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. NATO MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 237. NATO MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 239. NATO MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. NATO MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 258. CANADA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 259. CANADA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 260. CANADA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. CANADA MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 268. MEXICO MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 269. MEXICO MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 270. MEXICO MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. MEXICO MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 279. BRAZIL MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 280. BRAZIL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. BRAZIL MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 297. GERMANY MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 298. GERMANY MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 299. GERMANY MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 300. GERMANY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 309. FRANCE MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 310. FRANCE MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. FRANCE MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 318. RUSSIA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 319. RUSSIA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 320. RUSSIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. RUSSIA MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 323. ITALY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 328. ITALY MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 329. ITALY MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 330. ITALY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 331. ITALY MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. SPAIN MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 333. SPAIN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. SPAIN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 335. SPAIN MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 336. SPAIN MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 337. SPAIN MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 338. SPAIN MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 339. SPAIN MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 340. SPAIN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 341. SPAIN MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 342. CHINA MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 343. CHINA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 344. CHINA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 345. CHINA MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 346. CHINA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 347. CHINA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 348. CHINA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 349. CHINA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 350. CHINA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 351. CHINA MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 352. INDIA MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 353. INDIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 354. INDIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 355. INDIA MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 356. INDIA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 357. INDIA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 358. INDIA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 359. INDIA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 360. INDIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 361. INDIA MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 362. JAPAN MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 363. JAPAN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 364. JAPAN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 365. JAPAN MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 366. JAPAN MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 367. JAPAN MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 368. JAPAN MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 369. JAPAN MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 370. JAPAN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 371. JAPAN MICE MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 372. AUSTRALIA MICE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 373. AUSTRALIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 374. AUSTRALIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2032 (USD MILLION)
  • TABLE 375. AUSTRALIA MICE MODEL MARKET SIZE, BY AGE COHORT, 2018-2032 (USD MILLION)
  • TABLE 376. AUSTRALIA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 377. AUSTRALIA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 378. AUSTRALIA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 379. AUSTRALIA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2018-2032 (USD MILLION)

TABLE 3